Low-Level Resistance to Rifampin in Streptococcus pneumoniae
Rifampin is recommended for combination therapy of meningitis due to β-lactam-resistant Streptococcus pneumoniae. High-level rifampin resistance (MIC, ≥4 mg/liter) has been mapped to point mutations in clusters I and III of rpoB of the pneumococcus. The molecular basis of low-level resistance (MICs,...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
2003
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC149310/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12604513/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.3.863-868.2003 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|